(Q39367854)

11 September 2017

Off-label use of rituximab for systemic lupus erythematosus in Europe (English)

1 reference

systemic lupus erythematosus

11 September 2017

1 reference

1 reference

inferred from title

author

Guillermo Ruiz-Irastorza

26

1 reference

11 September 2017

Ronald van Vollenhoven

33

object named as

Ronald van Vollenhoven

1 reference

11 September 2017

8

Andrea Doria

1 reference

11 September 2017

15

David Isenberg

1 reference

11 September 2017

24

Manuel Ramos-Casals

1 reference

11 September 2017

13

Tom Huizinga

1 reference

11 September 2017

20

Xavier Mariette

1 reference

11 September 2017

11

Elisa Gremese

1 reference

11 September 2017

31

Gabriella Szücs

1 reference

11 September 2017

Monica Rydén-Aulin

1

1 reference

11 September 2017

Dimitrios Boumpas

2

1 reference

11 September 2017

Irene Bultink

3

1 reference

11 September 2017

Jose Luis Callejas Rubio

4

1 reference

11 September 2017

Luis Caminal-Montero

5

1 reference

11 September 2017

Antoni Castro

6

1 reference

11 September 2017

Agustín Colodro Ruiz

7

1 reference

11 September 2017

Thomas Dörner

9

1 reference

11 September 2017

Cristina Gonzalez-Echavarri

10

1 reference

11 September 2017

Frederic A Houssiau

12

1 reference

11 September 2017

Murat Inanç

14

1 reference

11 September 2017

Annamaria Iuliano

16

1 reference

11 September 2017

Søren Jacobsen

17

1 reference

11 September 2017

Juan Jimenéz-Alonso

18

1 reference

11 September 2017

Lászlo Kovács

19

1 reference

11 September 2017

Marta Mosca

21

1 reference

11 September 2017

Ola Nived

22

1 reference

11 September 2017

Joaquim Oristrell

23

1 reference

11 September 2017

Javier Rascón

25

1 reference

11 September 2017

Luis Sáez-Comet

27

1 reference

11 September 2017

Gonzalo Salvador Cervelló

28

1 reference

11 September 2017

Gian Domenico Sebastiani

29

1 reference

11 September 2017

Danilo Squatrito

30

1 reference

11 September 2017

Alexandre Voskuyl

32

1 reference

11 September 2017

6 September 2016

1 reference

11 September 2017

Lupus science & medicine

1 reference

11 September 2017

3

1 reference

11 September 2017

1

1 reference

11 September 2017

e000163

1 reference

Prolonged remission in Caucasian patients with SLE: prevalence and outcomes

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

The prevalences of some rheumatic diseases in western Turkey: Havsa study

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

The prevalence of rheumatic diseases in central Greece: a population survey

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

DANBIO: a nationwide registry of biological therapies in Denmark.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Rheumatoid arthritis registries in Sweden.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Lupus in Germany: analysis within the German lupus self-help organization (LULA)

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

British Society for Rheumatology Biologics Register

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

An open study of B lymphocyte depletion in systemic lupus erythematosus

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

The prevalence of systemic lupus erythematosus in Northern Ireland

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5013507

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

2 December 2018

1 reference

12 December 2020

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

12 December 2020

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

1 reference

12 December 2020

Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases

1 reference

12 December 2020

The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990

1 reference

12 December 2020

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

1 reference

12 December 2020

The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK

1 reference

12 December 2020

Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)

1 reference

12 December 2020

10.1136/LUPUS-2016-000163

Identifiers

DOI

1 reference

11 September 2017

0 references

1 reference